Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 16;8(9):e73181.
doi: 10.1371/journal.pone.0073181. eCollection 2013.

Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam: Findings From 13 Outpatient Clinics

Affiliations
Free PMC article

Trends in and Determinants of Loss to Follow Up and Early Mortality in a Rapid Expansion of the Antiretroviral Treatment Program in Vietnam: Findings From 13 Outpatient Clinics

Dam Anh Tran et al. PLoS One. .
Free PMC article

Abstract

Background: This study aims to describe the trends in and determinants of six month mortality and loss to follow up (LTFU) during 2005-2009 in 13 outpatient clinics in Vietnam.

Method: Data were obtained from clinical records of 3,449 Vietnamese HIV/AIDS patients aged 18 years or older who initiated ART between 1 January 2005 and 31 December 2009. Mantel-Haenszel chi-square test, log rank test were conducted to examine the trends of baseline characteristics, six month mortality and LTFU. Cox proportional hazards regression models were performed to compute hazard ratio (HR) and 95% Confidence Interval (CI).

Results: Though there was a declining trend, the incidence of six month mortality and LTFU remained as high as 6% and 15%, respectively. Characteristics associated with six month mortality were gender (HR females versus males 0.54, 95%CI: 0.34-0.85), years of initiation (HR 2009 versus 2005 0.54, 95%CI: 0.41-0.80), low baseline CD4 (HR 350-500 cells/mm(3) versus <50 cells/mm(3) 0.26, 95%CI: 0.18-0.52), low baseline BMI (one unit increase: HR 0.96, 95%CI: 0.94-0.97), co-infection with TB (HR 1.61, 95%CI: 1.46-1.95), history of injecting drugs (HR 1.58, 95%CI: 1.31-1.78). Characteristics associated with LTFU were younger age (one year younger: HR 0.97, 95%CI: 0.95-0.98), males (HR females versus males 0.82, 95%CI: 0.63-0.95), and poor adherence (HR 0.55, 95%CI: 0.13-0.87).

Conclusions: To reduce early mortality, special attention is required to ensure timely access to ART services, particularly for patients at higher risk. Patients at risk for LTFU after ART initiation should be targeted through enhancing treatment counselling and improving patient tracing system at ART clinics.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Trends in six month Mortality and LTFU by calendar years in 13 outpatient clinics in Vietnam (N = 3,449).

Similar articles

See all similar articles

Cited by 14 articles

See all "Cited by" articles

References

    1. Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al. .. (2010) Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS. 24 [14]:2263–70 doi: 10.1097/QAD.0b013e32833d45c5. - DOI - PMC - PubMed
    1. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, et al. .. (2010) An Empirical Approach to Defining Loss to Follow-up Among Patients Enrolled in Antiretroviral Treatment Programs. American Journal of Epidemiology. 171 [8]:924–31. - PMC - PubMed
    1. Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, et al. .. (2010) Understanding Reasons for and Outcomes of Patients Lost to Follow-Up in Antiretroviral Therapy Programs in Africa Through a Sampling-Based Approach. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53 [3]:405–11 doi: 10.1097/QAI.0b013e3181b843f0. - DOI - PMC - PubMed
    1. Wandeler G, Keiser O, Pfeiffer K, Pestilli S, Fritz C, et al. .. (2012) Outcomes of Antiretroviral Treatment Programs in Rural Southern Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59 [2]: e9-e16 doi: 0.1097/QAI.0b013e31823edb6a. - PMC - PubMed
    1. Auld AF, Mbofana F, Shiraishi RW, Sanchez M, Alfredo C, et al. .. (2011) Four-Year Treatment Outcomes of Adult Patients Enrolled in Mozambique's Rapidly Expanding Antiretroviral Therapy Program. PLoS ONE. 6 [4]: e18453. - PMC - PubMed

Substances

Grant support

The authors have no support or funding to report.
Feedback